Table 1.
Enteroids derived from | Distinct genes | Transcriptional / epigenetic | Culture period / passage number of enteroids | Human / mouse | Ref. | |
Region-specific | Duodenum | Gata4, Cybrd1, Slc40a1 | Increased mRNA | 12 weeks | Mouse | [25] |
Jejunum | Gata4, Lct | |||||
Ileum | Slc10a2, Ostb | |||||
Region- specific | Small bowel | CHGA, ATOH1 | Increased mRNA | Not mentioned | Human fetus | [172] |
Large bowel | LGR5, MYC | |||||
Region-specific | Terminal ileum | SLC5A1, CLDN15 | Increased mRNA | 3 months / 11 passages | Human children and adults | [26] |
SATB2AS1 | Increased methylation | |||||
Sigmoid colon | CFTR, SATB2 | Increased mRNA | ||||
IL6R, CLDN15 | Increased methylation | |||||
Disease-specific | Normal rectum | GATA2 | Increased methylation | 3-5 passages | Human children | [26] |
Gastric heterotopia in rectum | SATB2AS1 | |||||
Disease-specific | Colon of non-IBD patients | PLA2G2A, ZG16, CLCA1, AQP8, MUC12 | Increased mRNA | 1 passage | Human | [14] |
Colon of UC patients | LYZ, ANXA10 CLDN18 | |||||
Disease-specific | Sigmoid colon of non-IBD patients | LYZ (low) | mRNA expression | Not mentioned | Human | [14] |
Sigmoid colon of CD patients | LYZ (High) | |||||
Disease-specific | Healthy control | GREB1, TMEM173 | Increased methylation | Not mentioned | Human children: Terminal ileum, sigmoid colon | [28] |
CD patients | PDE1B |
Gata4: GATA binding protein 4, transcription factor specific to duodenum and jejunum; Cybrd1: Cytochrome b reductase 1 specific for iron uptake; Slc40a1: Solute carrier family 40 member 1, Fe2+ transporter ferroportin for iron uptake; Lct: Lactase-phlorizin hydrolase for dissacharide digestion; Slc10a2: Solute carrier family 10 member 2, apical sodium-dependent bile acid transporter; Ostb: Organic solute transporter beta for bile acid uptake; CHGA: Chromogranin A, a marker of enteroendocrine cells; ATOH1: Atonal BHLH Transcription Factor 1, key regulator of the Notch pathway; LGR5: Leucine rich repeat containing G protein-coupled receptor 5; MYC: MYC Proto-Oncogene, BHLH Transcription Factor; SLC5A1: Solute carrier family 5 member 1; CLDN15: Claudin 15; SATB2AS1: Special AT-rich sequence-binding protein 2 antisense 1; CFTR: Cystic fibrosis transmembrane conductance regulator; SATB2: Special AT-rich sequence-binding protein 2; IL6R: Interleukin-6 receptor; GATA2: GATA binding protein 2; PLA2G2A: Phospholipase A2 Group IIA, antibacterial enzyme; ZG16: Zymogen Granule Protein 16, mucus secreting cell marker; CLCA1: Chloride Channel Accessory 1, mucus secreting cell marker; AQP8: Aquaporin-8, water transporter; MUC12: Transmembrane mucin 12; LYZ: Lysozyme C; ANXA10: Annexin-10; CLDN18: Claudin 18; GREB1: Growth regulation by estrogen in breast cancer 1; TMEM173: Transmembrane protein 173; PDE1B: Phosphodiesterase 1B.